Status: Open for registration

RESURGE–ESSO Online Course on REtroperitoneal Sarcoma SURGEry

Share on

When

25-26.06.2026

Where

online

Level

Level 1

GAO Shuang

Aim of the course

The aim of this course is to help surgical oncologists dedicated to sarcoma, residents and fellows to gain insights into the sarcoma track. The course will provide a detailed approach to preoperative workout, multimodal management, as well as surgical anatomy and surgical technique for retroperitoneal sarcoma.

At the end of the course, participants will have a better knowledge on diagnosis and treatment of retroperitoneal sarcoma, and the most updated guidelines on treatment of primary disease.

This course is endorsed by

Media Partner

Educational methods

Lectures

Pre-recorded Lectures

Q&A

RE-LIVE Surgery

Clinical Cases

Main topics

Variations in RPS Surgery Across TARPSWG Centers

Retroperitoneal Liposarcoma

Neoadjuvant chemotherapy

Leiomyosarcoma

Relive surgery--Right Retroperitoneal Sarcoma, Left Retroperitoneal Sarcoma, Retroperitoneal Leiomyosarcoma

target participants

Surgical residents in the last two years of specialisation with clinical interest in soft tissue sarcoma

Surgical oncologists and sarcoma surgeons within 10 years of ending specialisation residency

Fellows of Complex General Surgical Oncology programs

General Surgeons interested in this rare tumor presentation

Candidates applying for UEMS EBSQ Examination in Surgical Oncology

Medical and radiation oncologists with interest in the treatment of sarcoma patients

Research Nurses – Case Manager involved in sarcoma patients care

Full course programme

Programme & faculty members

14:00 - 14:10 [LIVE] Introduction A. Gronchi

14:10 - 14:30 [LIVE] TARPSWG Lecture--Variations in RPS Surgery Across TARPSWG Centers: What Do Prospective Data Really Tell Us — and Do We Actually Need Harmonization? D. Strauss

14:30 - 14:40 [LIVE] Q&A

14:40 - 14:47 [Pre-recorded] Preoperative Imaging in Retroperitoneal Liposarcoma: Accurate Assessment of Disease Extent and Response to Neoadjuvant Therapy A. Vanzulli

14:47 - 15:00 [LIVE] Q&A

15:00 - 15:07 [Pre-recorded] Revisiting STRASS at Five Years: The Radiation Oncologist’s View on Evolving Care in Retroperitoneal Liposarcoma C. Sangalli

15:07 - 15:10 [LIVE] Q&A

15:10 - 15:17 [Pre-recorded] Neoadjuvant chemotherapy failure: are toxicity and progression real issues? C. Fabbroni

15:17 - 15:20 [LIVE] Q&A

15:20 - 15:35 [Pre-recorded] Shaping Surgical Strategy: A Historical Roadmap for Improving Outcomes in Retroperitoneal Liposarcoma A. Gronchi

15:35 - 15:40 [LIVE] Q&A

15:40 - 15:55 [Pre-recorded] Leiomyosarcoma: When Smaller Means Tougher — Technical Lessons Beyond Liposarcoma M. Fiore

15:55 - 16:00 [LIVE] Q&A

16:00 - 16:07 [Pre-recorded] Patient Frailty and Surgical Outcomes: Is there a role for prehabilitation? M. Baia

16:07 - 16:10 [LIVE] Q&A

16:10 - 16:17 [Pre-recorded] Postoperative morbidity: From Risk Recognition to Targeted Intervention C. Colombo

16:17 - 16:20 [LIVE] Q&A

16:20 - 16:30 [LIVE] Conclusion (plus Overview for Day 2) A. Gronchi and panelists